“Maintenance and Improvement of Skin Clearance Response With Brodalumab Among Patients With Moderate-to-Severe Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S23, https://doi.org/10.25251/skin.3.supp.23.